Register entryRepackager / relabeller
Evereen Shanghai Biotechnology Ltd
- Registered sites
- 1
- Drug products
- 8
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Relabelling
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Evereen Shanghai Biotechnology Ltd. | ShanghaiChina | Relabelling | 3023385987 |
Catalogue
Marketed products
8Showing 8 of 8.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | BETA Nicotinamide adenine dinucleotide | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Cabergoline | POWDER | BULK INGREDIENT |
| - | Calcipotriene Anhydrous | POWDER | BULK INGREDIENT |
| - | Copper Peptide (GHK- Cu) | POWDER | BULK INGREDIENT |
| - | Enclomiphene Citrate | POWDER | BULK INGREDIENT |
| - | Estriol | POWDER | BULK INGREDIENT |
| - | Mebendazole | POWDER | BULK INGREDIENT |
| - | Sildenafil Citrate | POWDER | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.